Sunday, September 25, 2022

Melbourne medtech start-up, Seer debuts on AFR Fast Starters list 2021

0
Creators of home-based clinical monitoring technology, Seer has made its debut on the Fast Starters 2021 list. In under five years since its launch, Seer has helped over 10,000 Australians access life-saving brain and heart monitoring care from the comfort of their homes.

Why and how we should all be using air quality monitors as Omicron rages

0
As the Omicron variant of the Covid-19 virus ravages its way through Australia equipping yourself with a carbon dioxide monitor is an essential device for added health security. A carbon dioxide monitor is a small device that measures air quality. It has become an incredibly important tool during this COVID era that we’re living in.

Aussie medicinal cannabis study gives hope to chronic pain patients

0
Little Green Pharma reported findings of a national study showing the positive effect of oral medicinal cannabis on chronic refractory pain in patients who have not experienced relief with existing pain medications including opioids, anti-inflammatories, and steroid treatments. 

Australian biotech firm CSL completes the acquisition of Vifor Pharma AG

0
CSL Limited is pleased to announce it has now received all necessary regulatory clearances for the acquisition of Vifor Pharma AG (Vifor) initially announced on 14 December 2021. CSL has set the settlement date of the public tender offer for Vifor for 9 August 2022. If the offer conditions that remain in effect until the settlement remain fulfilled until that date, shareholders who accepted the offer will receive the offer price for each share tendered into the offer on the settlement date, subject to the terms of the offer. CSL anticipates that it will hold more than 97% of Vifor Pharma AG shares upon the settlement of the offer and intends to have Vifor apply for the delisting of the Vifor Pharma AG Shares after the settlement.

An effective business COVID-safety plan is more important than ever

0
While browsing is off the cards in stores, for those who do choose to remain open to shoppers under current restrictions, they need to take the utmost care in ensuring their workplace is COVID safe, and that all visitors check-in via a QR code and wear a mask.

Queensland Fruit Processors pivots into growing health drink sector

0
Gold Coast-based Queensland Fruit Processors, which has been operating for the past 18 years and supplies a number of Australian hotels along with domestic and international airlines, is jumping on the all-natural juice juggernaut by launching a new brand, Burleigh Drinks Co.

Immediate psychological support to be rolled out for young job seekers

0
Employment services provider, Asuria, is pleased to announce a partnership with mental health and wellbeing experts, Back2Work, which will see young job seekers aged 15-24 eligible for the Department of Education, Skills and Employment’s ‘Transition to Work’ scheme, able to access much-needed mental health support services, through the placement of dedicated psychologists at Asuria’s job-seeking centres nationwide.

Women in their 40s need to watch out for surprising breast changes

0
Hollywood may have us all believing that having perky breasts right into our 60s is the norm, but the truth is far from it. As we age we deal with the side effects of having carried our breasts through decades of life, love, hundreds of outfits, tens of bras and even a few children to boot. At 40 it’s time to start paying some extra attention to our breast buddies.

GC Aesthetics® announces its expansion into the Brazilian market

0
GC Aesthetics®, Inc. (GCA), a privately-held medical tech firm providing Women Healthcare Aesthetic and Reconstructive Solutions, has announced today, its growth and expansion plans for the Brazilian market, the second largest Breast Augmentation market in the world. GC Aesthetics® has been executing an ambitious journey repositioning the brand and portfolio to offer a smart, unique, and clinically proven safe range of products to meet the needs of Brazilian women and surgeons. The Brazilian growth strategy includes 2 main pillars.

Health tech firm Covetrus names Margie Pritchard General Counsel

0
Covetrus® (NASDAQ: CVET), a global player in animal-health technology and services, announced the appointment of Margie B. Pritchard as General Counsel and Corporate Secretary, reporting to Ben Wolin, President and Chief Executive Officer (CEO) at Covetrus. Prior to being named as General Counsel, Pritchard most recently served as Vice President, Deputy Counsel at Covetrus, where she was responsible for corporate and board governance, public reporting, advising investor relations, employment matters including compensation, and providing general legal counsel to executive management.